- Home
- CHR vs CARM Comparison
CHR vs CARM Comparison
Compare CHR & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- CARM
- Stock Information
- Founded
- CHR 2016
- CARM 2016
- Country
- CHR China
- CARM United States
- Employees
- CHR N/A
- CARM N/A
- Industry
- CHR EDP Services
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- CARM Health Care
- Exchange
- CHR Nasdaq
- CARM Nasdaq
- Market Cap
- CHR 13.3M
- CARM 12.2M
- IPO Year
- CHR N/A
- CARM N/A
- Fundamental
- Price
- CHR $0.74
- CARM $0.37
- Analyst Decision
- CHR
- CARM Hold
- Analyst Count
- CHR 0
- CARM 5
- Target Price
- CHR N/A
- CARM $0.90
- AVG Volume (30 Days)
- CHR 757.3K
- CARM 25.7M
- Earning Date
- CHR 07-30-2025
- CARM 11-06-2025
- Dividend Yield
- CHR N/A
- CARM N/A
- EPS Growth
- CHR N/A
- CARM N/A
- EPS
- CHR 1.76
- CARM N/A
- Revenue
- CHR $147,134,000.00
- CARM $10,767,000.00
- Revenue This Year
- CHR N/A
- CARM N/A
- Revenue Next Year
- CHR N/A
- CARM N/A
- P/E Ratio
- CHR $0.41
- CARM N/A
- Revenue Growth
- CHR N/A
- CARM N/A
- 52 Week Low
- CHR $0.65
- CARM $0.14
- 52 Week High
- CHR $3.45
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- CHR 28.80
- CARM 55.76
- Support Level
- CHR $0.71
- CARM $0.34
- Resistance Level
- CHR $1.06
- CARM $0.44
- Average True Range (ATR)
- CHR 0.11
- CARM 0.05
- MACD
- CHR -0.02
- CARM 0.01
- Stochastic Oscillator
- CHR 15.54
- CARM 47.28
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.